Deoxycytidine Transport and Metabolism in Choroid Plexus

In vitro , the transport into and release of [ 3 H]deoxycytidine from the isolated choroid plexus, the anatomical locus of the blood‐cerebrospinal fluid barrier, were studied separately. By use of the ability of nitrobenzylthioinosine (NBTI) to inhibit deoxycytidine efflux from choroid plexus, the transport of 1 μM [ 3 H]deoxycytidine into choroid plexus at 37°C was measured. Deoxycytidine was transported into choroid plexus against a concentration gradient by a saturable process that depended on intracellular energy production, but not intracellular binding or metabolism. The Michaelis‐Menten constant ( K T ) for the active transport of deoxycytidine into choroid plexus was 15 μM . The active transport system for deoxycytidine was inhibited by naturally occurring nucleosides and deoxynucleosides, but not by 1 m M probenecid and 2‐deoxyribose or 100 μM cytosine and cytosine arabinoside. With less than 1 μM [ 3 H]deoxycytidine in the medium, the choroid plexus accumulated [ 3 H]deoxycytidine against a concentration gradient. However, approximately 50% of the [ 3 H]deoxycytidine was phosphorylated to [ 3 H]deoxycytidine nucleotides at a low extracellular [ 3 H]deoxycytidine concentration (6 n M ) in 15‐min incubations. This accumulation process depended, in part, on saturable intracellular phosphorylation. These studies provide further evidence that the choroid plexus contains an active nucleoside transport system of low specificity for deoxynucleosides and ribonucleosides, and a separate, saturable efflux system for deoxynucleosides which is very sensitive to inhibition by NBTI.